Study S001350

iPAVE - Imaging Pituitary ActiVation by Exendin

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03923114
Acronym: iPAVE
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Masking: NONE
Status: COMPLETED
Enrollment: 20
Start: 2019-05-23
Primary completion: 2024-04-03
Lead sponsor: Radboud University Medical Center
Conditions: Diabetes Mellitus, Type 2
Interventions: RADIATION:Ga-68-NODAGA-exendin-4 PET/CT
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Pituitary uptake of Ga-68-NODAGA-exendin [1.5 year]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0007290	Sex Differences in [ 68Ga]Ga-NODAGA-Exendin-4 Uptake in the Pituitary of Individuals With Type 2 Diabetes. Tokgöz S, Diabetes, obesity & metabolism	2026	Nonrandomized study	PMID 41766452 DOI	cites ClinicalTrials.gov:NCT03923114